Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Record History

See every version on ClinicalTrials.gov ↗

1. Notable Apr 5, 2025 Primary completion date: Mar 31, 2026 to Dec 31, 2030v4 Show 7 more changesShow less

   • Enrollment target: 234 to 240
   • Study sites: 14 to 26
   • Study completion date: Mar 31, 2029 to Dec 31, 2030
   • Interventions: CCRT (Radiation), CCRT (Radiation), Surgical debulking of bulky or multiple lymph nodes (Procedure) to CCRT (Other), Surgical debulking of lymph nodes + CCRT (Procedure)
   • Eligibility criteria expanded, about 20 words
   • Collaborators: 16 to 1
   • Publications: 17 to 29
2. Notable Feb 7, 2023 Trial status: Not Yet Recruiting to Recruiting

   • Study sites: 0 to 14
   • Eligibility criteria expanded, about 28 words
   • Collaborators: 15 to 16

   v3
3. Notable Jul 19, 2022 Start date: Jun 15, 2022 to Aug 1, 2022

   • Eligibility criteria revised
   • Collaborators revised (15)

   v2
4. Minor Jun 13, 2022 Study First Submitted

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.